Abstract
Pancreatic cancer is the fourth leading cause of cancer-related deaths in the USA. The high mortality rate is partly due to lack of effective treatments. This review summarizes the pathobiology and current treatment options for pancreatic cancer. Moreover, the review discusses the opportunities of developing novel therapies for pancreatic cancer provided by the progress in understanding the genetic mutations, tumor microenvironment, cancer stem cells, and drug delivery.
Publication types
-
Research Support, N.I.H., Extramural
-
Research Support, Non-U.S. Gov't
-
Review
MeSH terms
-
Animals
-
Antineoplastic Agents / administration & dosage*
-
Antineoplastic Agents / therapeutic use*
-
Combined Modality Therapy
-
Disease Progression
-
Drug Delivery Systems
-
Humans
-
Neoplastic Stem Cells / physiology
-
Pancreatic Neoplasms / drug therapy*
-
Pancreatic Neoplasms / genetics
-
Pancreatic Neoplasms / pathology*
-
Pancreatic Neoplasms / surgery
-
Stem Cell Transplantation